Psychiatr. praxi. 2013;14(1):15-17

Pharmacotherapy of borderline personality disorders in practice

MUDr.Bc.Aleš Grambal1,2,4, MUDr.Zuzana Grambalová3, prof.MUDr.Ján Praško, CSc.1,4
1 Klinika psychiatrie FN Olomouc
2 Radiologická klinika FN Olomouc
3 Neurologická klinika FN Olomouc
4 Univerzita Palackého v Olomouci

Psychotherapeutic care in patients suffering from borderline personality disorder (BPD) is indicated in the first place. Pharmacotherapy

is considered as adjuvant and often controversial way of treatment. The aim of the retrospective study is to report the pharmacological

approach in Olomouc and to comapre it with guidlines for BPD treatment. Patients with borderline personality disorder treated in 2011 on

department of psychiatry was included. Medication did not differ from the majority of best practices. But with a lack of strong evidence

about its effect, it seems appropriate to move towards its reduction.

Keywords: borderline personality disorder, pharmacotherapy

Published: December 1, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Grambal A, Grambalová Z, Praško J. Pharmacotherapy of borderline personality disorders in practice. Psychiatr. praxi. 2013;14(1):15-17.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Phillips KA, Gunderson JG. Personality disorders, in The American Psychiatric Press Textbook of Psychiatry, 3rd ed. Edited by Hales RE, Yudofsky SC, Talbott JA. Washington, DC, American Psychiatric Press 1999: pp.795-823.
    2. Koenigseberg HW, Kaplan RD, Gilmore MM, et al. The relationship between syndrome and personality disorder in DSM-III: experience with 2,462 patients. Am. J. Psychiatry 1985; 142: 207-212. Go to original source... Go to PubMed...
    3. Stone MH. Long-term outcome in personality disorders. In: Tyrer P, Stein G (eds): Personality disorder reviewed. London: Gaskell 1993: 321-345.
    4. Prasko J, Diveky T, Grambal A, et al. Transference and counter-transference in cognitive behavioral therapy. Biomedical Papers 2010; 154(3): 189-198. Go to original source... Go to PubMed...
    5. Aviram RB, Brodsky BS, Stanley B. Borderline personality disorder, stigma, and treatment implications. Harv Rev Psychiatry 2006; 14(5): 249-256. Go to original source... Go to PubMed...
    6. Rüsch, Nicolas MD*; Hölzer, Aurelia BSc*; Hermann, Christiane PhD+; Schramm, Elisabeth PhD*; Jacob, Gitta A. PhD*; Bohus, Martin MD?; Lieb, Klaus MD*; Corrigan, Patrick W. PsyD. Self-Stigma in Women With Borderline Personality Disorder and Women With Social Phobia. Journal of Nervous & Mental Disease: 2006; 194(10): 766-773. Go to original source... Go to PubMed...
    7. Reich JH, Green AI. Effects of personality disorders on outcome and treatment. J.Nerv. Ment. Dis. 1991; 179: 74-82. Go to original source... Go to PubMed...
    8. Pastucha P, Prasko J, Diveky T, Grambal A, Látalová K, Ticháčková A. Borderline personality disorder and dissociation - comparison with healthy controls, Activitas Nervosa Superior Rediviva 2009; 51(3-4).
    9. Sperry L. Cognitive behavior therapy of DSM-IV personality disorder. Taylor and Francis Group, London 1999: 201.
    10. Bender DS, Dolan RT, Sokol AE, et al. Treatment utilization by patients with personality disorders. Am J Psychiatry 2001; 158: 295-302. Go to original source... Go to PubMed...
    11. American Psychiatric Association: Practice guideline for the treatment of patients with borderline personality disorder. Am J Psychiatry 2001; 158:1-52. http://psychiatryonline.org/content.aspx?bookid=28§ionid=1682658.
    12. Lieb K, Völlm B, Rücker G, Timmer A, Stoffers JM. Pharmacotherapy for borderline personality disorder: Cochrane systematic review of randomised trials. Br J Psychiatry 2010; 196(1): 4-12. Go to original source... Go to PubMed...
    13. Kendall T, Burbeck R, Bateman A. Pharmacotherapy for borderline personality disorder: NICE guideline. Br J Psychiatry 2010; 196(2): 158-159. Go to original source... Go to PubMed...
    14. Praško J. Hraniční porucha osobnosti. In: Seifertová D, Prasko J, Horáček J, Hoschl C. (eds.): Postupy v léčbě psychických poruch. Algoritmy České neurofarmakologické společnosti. Amepra, Medical Tribune, Praha 2008: 401-426.
    15. Pascual JC, Martín-Blanco A, Soler J, Ferrer A, Tiana T, Alvarez E, Pérez V. A naturalistic study of changes in pharmacological prescription for borderline personality disorder in clinical practice: from APA to NICE guidelines. Int Clin Psychopharmacol 2010; 25(6): 349-355. Go to original source... Go to PubMed...

    Return to the content


    Psychiatry for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.